Both in Pharmaceuticals
Nektar Therapeutics vs LB Pharmaceuticals
Over the past year NKTR returned −31.3% and LBRX returned +147.6%; their daily moves had a correlation of 0.17.
NKTR −31.3% LBRX +147.6%Growth of $1, one year, split-adjusted
| Metric | NKTR | LBRX |
|---|---|---|
| Price | $38.48 | $40.85 |
| Market cap | $1.31B | $1.32B |
| Today | +1.91% | +1.29% |
| 1 month | −3.6% | +19.2% |
| 6 months | −54.8% | +27.7% |
| Year to date | −9.0% | +83.5% |
| 1 year | −35.8% | +152.6% |
| Revenue growth (YoY) | −9.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −401.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 24.1× | — |
| Net cash | $684.3M | $327.8M |
| Dividend yield | — | — |
| Volatility (60d) | 70.0% | 51.5% |
| Short % of float | 21.0% | 23.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).